ACCESS Newswire

Too Consult Sweden AB

Share
New Safety Research Sheds Light on Crucial Child Safety Product Concerns

Critical findings from a comprehensive study on child safety products raise urgent concerns, prompting a call for enhanced safety standards and heightened vigilance among parents and caregivers

BREDARYD, SWEDEN / ACCESSWIRE / September 28, 2023 / In a dedicated effort to enhance child safety standards, Too Consult Sweden AB feels obliged to announce the results of our extensive investigation into the safety of retractable "Safety Barriers" (known in Europe) and "Expansion Gates" (known in the U.S.). This comprehensive study encompassed a meticulous analysis of numerous models available in both European and U.S. markets.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Testing at the Research Institutes of Sweden (RISE) - Borås, Sweden

Physical laboratory tests were meticulously conducted by the esteemed state-owned Research Institutes of Sweden (RISE), while chemical evaluations were carried out by SGS-CSTC (Standards Technical Services Co., Ltd) in China.

The tests covered the following aspects:

  • Product Marking
  • Purchase Information
  • Instruction for Use - Manual
  • Product Registration Card (CPSC 16 CFR 1130), only U.S.
  • Protective Height
  • Gaps (Hip Probe/Small Torso)
  • Protrusion Hazards (Ball-Chain), only EU
  • Chemical content test of fabric according to:
    * EU: EN71-3:2019+A1:2021, 2009/48/EC TSD
    * U.S.: 16 CFR 1303 + CPSIA and HR 4040, 16 CFR 1307/CPSIA section 108 and Moorberg V, North States Industries Inc. out of court settlement and California State, AB 652.

Our findings, which bear significant implications for parents and caregivers alike, highlight the widespread availability of safety devices in both territories. The 24 models subjected to rigorous examination encompassed a wide array of over 90 unique brand names, with our analysis laser-focused on key clauses from the European standard EN1930:2011 and the U.S. standard ASTM F1004-22.

The outcome of our comprehensive testing has unveiled critical concerns, as certain models exhibited defects that have the potential to result in severe or, tragically, even fatal injuries to children. Conversely, a select subset of models showcased a safety design that maximizes child protection.

These findings highlight a troubling pattern of neglect or inadequate comprehension of safety standards within both manufacturers and merchants. Furthermore, they underscore the shortcomings of government consumer watchdogs and consumer organizations in monitoring dangerous products within their respective markets.

For more in-depth information about the study and our testing results, please visit the following link: https://medium.com/too-consult-sweden/safety-research-reveals-alarming-dangers-in-many-retractable-child-safety-gates-sold-on-online-d91c73a05236. An overview of the testing results can be viewed here: https://vimeo.com/867816088

In light of these paramount findings, Too Consult Sweden AB is committed to disseminating this crucial information to the public. Further insights, in-depth analysis, and comprehensive details regarding our research can be provided.

For media inquiries, please contact:

Mattias Larsson, Too Consult Sweden AB

+46 705 700 262

info@tooconsult.se

Contact Information

Mattias Larsson
Manager
info@tooconsult.se
+46 705 700 262

Related Images

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Testing at the Research Institutes of Sweden (RISE) - Borås, Sweden
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Protective Height Testing - Fail

SOURCE: Too Consult Sweden AB

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/787843/new-safety-research-sheds-light-on-crucial-child-safety-product-concerns

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Black Iron Congratulates the U.S. and Ukraine on Their Minerals Deal and Aims to Help Pave the Way With Its Highly Advanced Ukraine New Mining Project5.5.2025 07:16:00 CEST | Press release

U.S. and Ukraine entered into a landmark agreement to jointly develop Ukraine's vast mineral resources. Black Iron (TSX:BKI) is developing the most advanced project to construction in Ukraine. Black Iron's successful construction and operation will create a development roadmap for investments under the U.S. - Ukraine Minerals Agreement. TORONTO, ON / ACCESS Newswire / May 5, 2025 / Black Iron Inc. ("Black Iron" or the "Company") (TSX:BKI)(OTCPK:BKIRF)(FWB:BIN) congratulates Ukraine and the United States governments on signing a landmark agreement to jointly develop Ukraine's vast mineral resources - a strategic move designed to accelerate post-war reconstruction and reduce global dependency on hostile-state supply chains. With potentially trillions of dollars worth of untapped mineral resources and growing Western support, Ukraine is positioning itself as a future powerhouse in the critical minerals sector. The challenge is that there hasn't been a new large-scale mine constructed in U

Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards5.5.2025 06:45:00 CEST | Press release

With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks VILNIUS, LT / ACCESS Newswire / May 5, 2025 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech's new Gene Therapy Center with dedicated cGMP facilities for virus-related projects. With six newly established, identical BSL-2 laboratories now operational, Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks. Additionally, the company has expanded its capabilities to perform GMP-compliant manufacturing and testing under BSL-3 condition

BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization5.5.2025 03:05:00 CEST | Press release

VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that its first national level patent filing has been accepted by the Eurasian Patent Organization (EAPO). The EAPO has confirmed the Company‘s core patent claims, namely: novelty, inventive step, and industrial applicability. BioNxt's flagship patent filing, which received a positive international examination report from the European Patent Office, reported September 9, 2024, is a comprehensive patent application for sublingual delivery of anticancer drugs for the treatment of autoimmune neurodegenerative diseases. This patent family provides numerous proprietary product development and commercialization opportunities, including BioNxt's lead product, BNT23001, a sublingual thin-film formulation of Cladribine for the treatment of multiple sclerosis (MS). The EA

Polaris Renewable Energy Announces Q1 2025 Results1.5.2025 07:45:00 CEST | Press release

TORONTO, ON / ACCESS Newswire / May 1, 2025 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the three months ended March 31, 2025. This earnings release should be read in conjunction with the Company's condensed consolidated interim financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise. 2025 HIGHLIGHTS First quarter consolidated energy production of 216,344 MWh, compared to 213,434 MWh in the first quarter last year. The modest increase is mainly attributable to the production of the Puerto Rican wind farm which was acquired on March 3, 2025 and did not contribute to consolidated energy production during the comparative quarter of 2024. The Company generated $20.3 million in revenue

Polaris Renewable Energy Declares Quarterly Dividend1.5.2025 07:45:00 CEST | Press release

TORONTO, ON / ACCESS Newswire / May 1, 2025 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has declared a quarterly dividend of US$0.15 per common share outstanding. This dividend will be paid on May 23rd to shareholders of record at the close of business on May 12th. The dividend is an "eligible dividend" as designated for Canadian federal, provincial, and territorial income tax purposes. The board of directors of Polaris Renewable Energy remains committed to paying a quarterly dividend and will evaluate further dividend increases, as appropriate, going forward. About Polaris Renewable Energy Inc. Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the acquisition, development, and operation of renewable energy projects in Latin America & the Caribbean. We are a high-performing and financially sound contributor to the energy transition. The Company's operations inclu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye